Last reviewed · How we verify

NCT04663022: PSIC-TSA

Influence of the Sensory Profile of Deaf Children With Autism Spectrum Disorders on the Outcome of Cochlear Implantation

Completed Last updated 19 August 2022
What this trial tests

trial testing Dunn's sensory profile questionnaire in Deafness in 33 participants. Completed in 31 December 2021.

Timeline
1 December 2020
Primary endpoint
10 May 2021
31 December 2021

Quick facts

Lead sponsorUniversity Hospital, Toulouse
StatusCompleted
Study typeOBSERVATIONAL
Enrollment33
Start date1 December 2020
Primary completion10 May 2021
Estimated completion31 December 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

Adults 15 Months to 10, any sex, with Deafness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An unpublished study conducted at Toulouse University Hospital revealed that 30% of implanted children with Autism Spectrum Disorders abandon their implant, while 70% of them keep it. The aim of this study is to evaluate the causes of this disparity, which is much greater than in children with cochlear implants without associated Autism Spectrum Disorders. Our problem is as follows: do the sensory hypersensitivity and hyposensitivity of deaf children with Autism Spectrum Disorders have an effect on the expected results after a cochlear implantation from a language and auditory reaction point of view?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Deafness

Currently open trials in the same condition.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04663022.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing